bUniversity of Colorado School of Medicine-Anschutz Medical Campus, Department of Pediatrics, Section on Nutrition and Lifestyle Medicine, Nutrition Obesity Research Center at the University of ...

A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation—and pointing to a surprising new ally in the fight against type 2 diabetes. Using mass ...

A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation - and pointing to a surprising new ally in the fight against type 2 diabetes. Published ...

Columbus Community Hospital will be hosting Diabetes Awareness Day from 4:30 to 7 p.m. Thursday, Oct. 2, in the hospital’s first-floor conference center. The event will include cooking demonstrations, ...

In this phase 3, multinational, randomized, double-blind trial, we examined the safety and efficacy of once-daily orforglipron at doses of 6 mg, 12 mg, or 36 mg, as compared with placebo (assigned in ...

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight. However, a new population-wide study ...